B-lymphocyte

(redirected from B-lymphocytes)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to B-lymphocytes: Plasma B cells

B lymphocyte

also B-lym·pho·cyte  (bē′lĭm′fə-sīt′)
n.
See B cell.

B-lymphocyte

n
(Biochemistry) a type of lymphocyte, originating in bone marrow, that produces antibodies. Also called: B-cell See also T-lymphocyte
Mentioned in ?
References in periodicals archive ?
This cell line will enable Acceptys to directly isolate and capture antibody producing B-lymphocytes from targeted patient populations (e.
The two major populations of lymphocytes are B-lymphocytes (B-cells) and T-lymphocytes (T-cells).
Elaboration of such viral proteins as LMP1, essential to the immortalization of EBV-infected B-lymphocytes, may affect EBV infection of T lymphocytes, although studies suggest otherwise (59).
Because more than 80% of non-Hodgkin's lymphomas originate from clonal proliferations of B-lymphocytes, it is apparent why most examples of MLLP are of B-phenotype.
While no one is claiming miracles, Lennon and neurologist Moses Rodriguez say some severely crippled mice improved "dramatically" after treatment with antibodies belonging to a class called immunoglobulin G (IgG), produced by white blood cells called B-lymphocytes.
The body has two main types of lymphocytes that can develop into lymphomas: B-lymphocytes (B-cells) and T-lymphocytes (T-cells).
It was regarded as a monoclonal B-cell disorder characterized by an asymptomatic monoclonal expansion of circulating B-lymphocytes in the blood and could not fulfill any criteria for a lymphoid malignancy.
Hematological aspects: Mean squares demonstrated that T-lymphocytes, b-lymphocytes, neutrophils and hemoglobin of experimental rabbits affected significantly due to treatments and time intervals however, non- significant behavior for leukocytes, monocytes and eosinophils was observed (Table 3).
A number of B-lymphocytes against to the control group already in non- pregnancy has the valid increase (CD19+), and is tending to increase with pregnancy.
The patent covers the use of monoclonal antibodies that bind to the CD22 antigen on B-lymphocytes for treating autoimmune disorders.
We speculate that the negative effect of Nef on the mobility of T-helper cells has far reaching consequences for the efficient formation of antibodies by B-lymphocytes in the patient.